NCT00766324 2014-05-28
PHA-739358 for Treatment of Hormone Refractory Prostate Cancer
Nerviano Medical Sciences
Phase 2 Completed
Clinical Trials
3 trialsNCT00872300 2014-05-28
PHA-739358 for the Treatment of Multiple Myeloma
Nerviano Medical Sciences
Phase 2 Terminated
NCT00335868 2013-12-18
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
National Cancer Institute (NCI)
Phase 2 Unknown